NADMED, a spin-out from the University of Helsinki, has partnered with the US laboratory Doctor’s Data to offer NAD biomarker measurement services to healthcare providers across the United States. This partnership enables healthcare practitioners to access the newly developed NAD Profile test, allowing them to monitor metabolic and mitochondrial health effectively.
Doctor’s Data has utilized NADMED's assay to develop the NAD Profile, a lab-tested method for measuring NAD+ and NADH from whole blood. This advancement aims to help practitioners establish and monitor NAD levels over time, contributing to the growing interest in metabolic health and personalized healthcare solutions.
The partnership represents a strategic step for NADMED's international expansion, enhancing its footprint in the US healthcare market and meeting the increased demand for advanced metabolic health assessments.